These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 30070899)
21. Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis. Sirenko O; Hancock MK; Hesley J; Hong D; Cohen A; Gentry J; Carlson CB; Mann DA Assay Drug Dev Technol; 2016 Sep; 14(7):381-94. PubMed ID: 27494736 [TBL] [Abstract][Full Text] [Related]
22. High-throughput identification of small molecules that affect human embryonic vascular development. Vazão H; Rosa S; Barata T; Costa R; Pitrez PR; Honório I; de Vries MR; Papatsenko D; Benedito R; Saris D; Khademhosseini A; Quax PH; Pereira CF; Mercader N; Fernandes H; Ferreira L Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3022-E3031. PubMed ID: 28348206 [TBL] [Abstract][Full Text] [Related]
23. High-throughput cardiac safety evaluation and multi-parameter arrhythmia profiling of cardiomyocytes using microelectrode arrays. Gilchrist KH; Lewis GF; Gay EA; Sellgren KL; Grego S Toxicol Appl Pharmacol; 2015 Oct; 288(2):249-57. PubMed ID: 26232523 [TBL] [Abstract][Full Text] [Related]
24. The impact of in vitro cell culture duration on the maturation of human cardiomyocytes derived from induced pluripotent stem cells of myogenic origin. Lewandowski J; Rozwadowska N; Kolanowski TJ; Malcher A; Zimna A; Rugowska A; Fiedorowicz K; Łabędź W; Kubaszewski Ł; Chojnacka K; Bednarek-Rajewska K; Majewski P; Kurpisz M Cell Transplant; 2018 Jul; 27(7):1047-1067. PubMed ID: 29947252 [TBL] [Abstract][Full Text] [Related]
28. Testing for developmental neurotoxicity using a battery of in vitro assays for key cellular events in neurodevelopment. Harrill JA; Freudenrich T; Wallace K; Ball K; Shafer TJ; Mundy WR Toxicol Appl Pharmacol; 2018 Sep; 354():24-39. PubMed ID: 29626487 [TBL] [Abstract][Full Text] [Related]
29. High Throughput Measurement of Ca++ Dynamics in Human Stem Cell-Derived Cardiomyocytes by Kinetic Image Cytometery: A Cardiac Risk Assessment Characterization Using a Large Panel of Cardioactive and Inactive Compounds. Lu HR; Whittaker R; Price JH; Vega R; Pfeiffer ER; Cerignoli F; Towart R; Gallacher DJ Toxicol Sci; 2015 Dec; 148(2):503-16. PubMed ID: 26358003 [TBL] [Abstract][Full Text] [Related]
30. Cardiotoxicity screening: a review of rapid-throughput in vitro approaches. Li X; Zhang R; Zhao B; Lossin C; Cao Z Arch Toxicol; 2016 Aug; 90(8):1803-16. PubMed ID: 26676948 [TBL] [Abstract][Full Text] [Related]
31. High-throughput screen for compounds that modulate neurite growth of human induced pluripotent stem cell-derived neurons. Sherman SP; Bang AG Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29361516 [TBL] [Abstract][Full Text] [Related]
32. Smooth Muscle Progenitor Cells Derived From Human Pluripotent Stem Cells Induce Histologic Changes in Injured Urethral Sphincter. Li Y; Wen Y; Wang Z; Wei Y; Wani P; Green M; Swaminathan G; Ramamurthi A; Pera RR; Chen B Stem Cells Transl Med; 2016 Dec; 5(12):1719-1729. PubMed ID: 27460854 [TBL] [Abstract][Full Text] [Related]
33. High throughput physiological screening of iPSC-derived cardiomyocytes for drug development. Del Álamo JC; Lemons D; Serrano R; Savchenko A; Cerignoli F; Bodmer R; Mercola M Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1717-27. PubMed ID: 26952934 [TBL] [Abstract][Full Text] [Related]
34. High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells. Sirenko O; Hesley J; Rusyn I; Cromwell EF Assay Drug Dev Technol; 2014; 12(1):43-54. PubMed ID: 24229356 [TBL] [Abstract][Full Text] [Related]
35. Miniaturized skeletal muscle tissue fabrication for measuring contractile activity. Yoshioka K; Ito A; Arifuzzaman M; Yoshigai T; Fan F; Sato KI; Shimizu K; Kawabe Y; Kamihira M J Biosci Bioeng; 2021 Apr; 131(4):434-441. PubMed ID: 33358352 [TBL] [Abstract][Full Text] [Related]
36. A Protocol for In Vitro High-Throughput Chemical Susceptibility Screening in Differentiating NT2 Stem Cells. Menzner AK; Gilbert DF Methods Mol Biol; 2017; 1601():61-70. PubMed ID: 28470517 [TBL] [Abstract][Full Text] [Related]
37. Specific prediction of clinical QT prolongation by kinetic image cytometry in human stem cell derived cardiomyocytes. Pfeiffer ER; Vega R; McDonough PM; Price JH; Whittaker R J Pharmacol Toxicol Methods; 2016; 81():263-73. PubMed ID: 27095424 [TBL] [Abstract][Full Text] [Related]
38. Human iPSC-based cardiac microphysiological system for drug screening applications. Mathur A; Loskill P; Shao K; Huebsch N; Hong S; Marcus SG; Marks N; Mandegar M; Conklin BR; Lee LP; Healy KE Sci Rep; 2015 Mar; 5():8883. PubMed ID: 25748532 [TBL] [Abstract][Full Text] [Related]
39. High-Throughput Neurite Outgrowth Assay Using GFP-Labeled iPSC-Derived Neurons. Zhang L; Li S; Xia M Curr Protoc; 2022 Sep; 2(9):e542. PubMed ID: 36102902 [TBL] [Abstract][Full Text] [Related]
40. A high-throughput screen for teratogens using human pluripotent stem cells. Kameoka S; Babiarz J; Kolaja K; Chiao E Toxicol Sci; 2014 Jan; 137(1):76-90. PubMed ID: 24154490 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]